Shilajit, a sticky, tar-like resin formed from the decomposition of plant matter in the Himalayan mountains, has gained popularity as a dietary supplement due to its rich content of fulvic acid, humic substances, and minerals. Traditionally used in Ayurvedic medicine as a rejuvenator, modern interest focuses on its potential benefits for energy, testosterone support, and overall vitality. However, its safety profile raises significant concerns, particularly regarding contamination with heavy metals and other impurities. While purified forms may be tolerated in short-term use by healthy adults, raw or poorly processed products pose real risks.
This article examines the documented side effects, contamination issues, and populations who should exercise caution or avoid Shilajit altogether.
Understanding Shilajit and Its Potential Risks
Shilajit forms naturally over centuries in high-altitude rock crevices. In its raw state, it contains a complex mix of organic compounds and inorganic minerals. Proper purification processes aim to reduce harmful impurities while preserving bioactive components like fulvic acid.
Despite traditional claims of safety, modern analysis reveals variability in product quality. The U.S. Food and Drug Administration (FDA) does not regulate dietary supplements strictly, meaning purity and potency can differ widely between brands. Some "purified" products have even shown higher levels of certain toxins than raw resin due to inadequate or improper processing.
Heavy Metals and Contamination Risks
The primary safety concern with Shilajit is heavy metal contamination. Raw Shilajit can naturally accumulate metals from the soil and rock environment, including:
- Lead (Pb)
- Arsenic (As)
- Mercury (Hg)
- Cadmium (Cd)
- Thallium (Tl)
- Aluminum and others
Studies and reports have found that some samples exceed permissible limits set by the World Health Organization (WHO) and FDA. For instance, lead levels in certain raw samples have been reported three to four times higher than accepted safety thresholds. Inorganic arsenic and other toxins also appear in variable concentrations.
Chronic exposure to these metals can lead to serious health issues, including:
- Kidney damage
- Neurological symptoms (fatigue, cognitive impairment, neuropathy)
- High blood pressure
- Gastrointestinal distress
- Developmental delays (particularly concerning for vulnerable groups)
A 2025 study highlighted elevated thallium in some commercial Shilajit supplements, sometimes higher than in unprocessed material. Thallium is highly toxic and can affect the central nervous system.
Other contaminants may include mycotoxins (from fungal growth), microbial organisms (bacteria, viruses), and adulterants added during manufacturing. Poor sourcing from non-Himalayan or low-altitude regions increases these risks. Even some processed products fail independent lab tests for heavy metals.
FDA and regulatory warnings: The FDA has issued alerts about Ayurvedic products, including those containing Shilajit-like resins, contaminated with lead, mercury, and arsenic. Similar concerns have appeared in advisories from Health Canada and other bodies. Consumers are urged to avoid unapproved or untested products.
Reported Side Effects
In clinical studies using purified Shilajit at doses of 250–500 mg daily (or up to 2 g for short periods), most participants tolerate it well, with no serious adverse events in many small trials. However, reported side effects include:
- Mild gastrointestinal issues — Bloating, abdominal discomfort, nausea, or diarrhea.
- Headaches, dizziness, or sore throat — Possibly linked to fulvic acid or mineral content.
- Allergic reactions — Rare but documented, including one case of anaphylaxis (severe reaction with low blood pressure and breathing difficulty). Skin redness has also been noted.
- Cardiovascular or blood pressure changes — Some reports of increased blood pressure or heart rate fluctuations (mostly from animal data or anecdotal evidence).
- Other — Disorientation, fatigue, or allergic responses in sensitive individuals.
Long-term safety data remains limited. Most human trials are small, short-duration (weeks to a few months), and lack robust post-marketing surveillance. Processed Shilajit appears safer than crude forms, but individual responses vary.
Overdosing or combining with certain substances may amplify risks, though specific toxicity thresholds are not well-established.
Who Should Avoid Shilajit or Use It with Caution?
Certain groups face heightened risks and should generally avoid Shilajit or consult a healthcare professional before use:
1. Pregnant and breastfeeding women — Insufficient safety data exists. Heavy metals could harm fetal development or pass into breast milk, potentially causing neurological or developmental issues. Avoidance is strongly recommended.
2. Individuals with hormone-sensitive conditions — Shilajit may influence testosterone and other hormones. Those with breast, ovarian, or prostate cancers (or history thereof) should avoid it due to potential exacerbation of hormone-dependent growth.
3. People with iron overload disorders — Such as hemochromatosis. Shilajit contains iron and other minerals that could worsen accumulation.
4. Patients with kidney, liver, or heart disease — Contaminants place additional strain on these organs. Those with gout, high uric acid, or kidney stone history may also need to avoid due to mineral content.
5. Individuals on certain medications:
- Antidiabetic drugs (risk of excessive blood sugar lowering).
- Blood pressure or heart medications.
- Blood thinners/anticoagulants.
- Thyroid medications or immunosuppressants.
- Aspirin or chemotherapy agents (potential interactions noted in reviews).
6. Children — Lack of safety data; not recommended.
7. People with allergies — Especially to bee products (some Shilajit processing involves similar substances) or those with mast cell activation syndrome (MCAS), where severe reactions are possible.
8. Anyone undergoing surgery — Stop use at least two weeks prior due to potential effects on blood sugar and bleeding risk.
Healthy adults considering Shilajit should start with low doses of high-quality, purified products and monitor for any adverse reactions.
How to Minimize Risks: Choosing Safe Shilajit
To reduce contamination risks:
- Select purified, lab-tested products — Look for third-party testing (e.g., for heavy metals, microbes, and fulvic acid content) by reputable labs like NSF, USP, or independent facilities. Certificates of Analysis (COAs) should be available.
- Prefer resin over powders/capsules when possible — Authentic resin dissolves in warm water (a simple authenticity test), though this is not foolproof.
- Choose reputable Himalayan-sourced brands — With transparent supply chains and high-altitude origins. Avoid suspiciously cheap products or those without clear purification details.
- Check for standardized fulvic acid content — Typically 50% or more in quality extracts.
- Follow dosage guidelines — Commonly 250–500 mg daily of purified Shilajit; do not exceed without professional advice.
Even with these steps, no supplement is risk-free. The FDA advises caution with Ayurvedic products in general due to contamination patterns.
Conclusion
While purified Shilajit shows a relatively favorable short-term safety profile in limited clinical data, the risks of heavy metal contamination, variable product quality, and potential interactions cannot be ignored. Raw or untested Shilajit should never be consumed. Individuals with pre-existing conditions, those on medications, or pregnant/breastfeeding women should avoid it or seek medical advice.
Consumers bear responsibility for verifying product quality through independent testing and reputable sources. Consulting a healthcare provider is essential before starting any new supplement, especially one with Shilajit’s complex composition. More large-scale, long-term human studies are needed to fully establish its safety across diverse populations.
Prioritizing evidence-based choices and quality over hype remains the best approach to minimizing risks while exploring traditional wellness options.